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Available online 23 April 2016Background:We have previously shown that high fat (HF) feeding during pregnancy primes the development of
non-alcoholic steatohepatits (NASH) in the adult offspring. However, the underlying mechanisms are unclear.
Aims: Since the endogenous molecular clock can regulate hepatic lipid metabolism, we investigated whether
exposure to a HF diet during development could alter hepatic clock gene expression and contribute to NASH
onset in later life.
Methods: Femalemicewere fed either a control (C, 7% kcal fat) or HF (45% kcal fat) diet. Offspringwere fed either
a C or HF diet resulting in four offspring groups: C/C, C/HF, HF/C and HF/HF. NAFLD progression, cellular redox
status, sirtuin expression (Sirt1, Sirt3), and the expression of core clock genes (Clock, Bmal1, Per2, Cry2) and
clock-controlled genes involved in lipid metabolism (Rev-Erbα, Rev-Erbβ, RORα, and Srebp1c) were measured
in offspring livers.
Results: Offspring fed a HF diet developed NAFLD. However HF fed offspring of mothers fed a HF diet developed
NASH, coupled with signiﬁcantly reduced NAD+/NADH (p b 0.05, HF/HF vs C/C), Sirt1 (p b 0.001, HF/HF vs C/C),
Sirt3 (p b 0.01, HF/HF vs C/C), perturbed clock gene expression, and elevated expression of genes involved lipid
metabolism, such as Srebp1c (p b 0.05, C/HF and HF/HF vs C/C).
Conclusion: Our results suggest that exposure to excess dietary fat during early and post-natal life increases the
susceptibility to develop NASH in adulthood, involving altered cellular redox status, reduced sirtuin abundance,
and desynchronized clock gene expression.








Non-alcoholic fatty liver disease (NAFLD) is currently the most
common cause of chronic liver disease worldwide, and is present in a
third of the general population and themajority of individualswith obe-
sity and type 2 diabetes [1,2]. In its milder form, NAFLD is characterized
by excessive intra-hepatocyte triglyceride (TG) accumulation (hepatic
steatosis). In advanced stages steatosis is coupled with inﬂammation
and termed non-alcoholic steatohepatits (NASH) [3], which candisease; NASH, non-alcoholic
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Bruce).
. This is an open access article undereventually result in liver failure. NAFLD is commonly associated
with older individuals; however, recent evidence suggests that
NAFLD is increasingly common in young adults, children and adoles-
cents [4–6]. The precise mechanisms underlying the premature
onset of liver disease are unclear.
A substantial body of evidence suggests that early life is a critical
period of plasticity, in which the developing organism physiologically
adapts to its surrounding environment. In some cases this may be
advantageous [7,8], however, imbalanced nutrition during early life
may also have deleterious effects on the development of key metabolic
organs. This is particularly true of the liver, which undergoes important
maturation stages during late gestation and early postnatal life. Hence,
the liver is highly susceptible to chronic maternal high fat (HF) diets,
which can lead to a NAFLD phenotype in offspring independent of
maternal and offspring obesity [9]. In addition, we have previously
shown in mice, that exposure to a high fat (HF) diet during gestation
and lactation primes the development of the severe form of fatty liver
(NASH) in adult offspring, involving impaired mitochondrial functionthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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studies support the notion that earlyHF exposure can prime the onset of
NAFLD in adulthood. In a ratmodel of high fat feeding during pregnancy
only, obese mothers gave rise to offspring with altered transcriptional
and epigenetic regulation of key regulators of fatty acid oxidation such
as peroxisome proliferator-activated receptor (PPAR)α [11]. Similarly
offspring of HF fed dams have shown increased expression of the
lipogenic transcription factor, Srebp1c [12,13].
Nutritional status is constantly being assessed by transcriptional
networks that control lipid homeostasis [14]. In mammals, one such
network is the endogenous molecular clock network, which mediates
transcriptional changes controlling a number of metabolic outputs
[15]. While the suprachiasmatic nucleus (SCN) of the hypothalamus is
the central pacemaker, molecular clocks also exist in peripheral tissues
such as the liverwhere they can be entrained by local nutrient availabil-
ity [16]. The core components of the clock network Clock, Bmal1, Per1,
Per2, Cry1 and Cry2, self-regulate through transcriptional feedback
loops resulting in 24-hour oscillatory patterns of gene expression [17,
18]. Interestingly, genetic disruption of the clock genes and changes in
the canonical 24-hour oscillatory patterns can lead to fatty liver disease
[19,20]. This is likely due to the fact that the core clock genes transcrip-
tionally regulate downstream clock controlled genes (CCGs) with
important roles in hepatic lipid metabolism. For example, Bmal1 has
been shown to directly regulate CCGs involved in hepatic carbohydrate
and lipid metabolism [21]. In addition, the Rev-Erb and ROR nuclear
transcription factors are able to activate and repress Bmal1 expression
respectively, thus ﬁne tuning the circadian regulation of metabolic
genes [22]. The Rev-Erb isoforms, previously considered as accessory
components of the clock system, have been shown to coordinate a
number of genes involved in lipid metabolism [23]. Recent studies
using Rev-Erb agonists have revealed alterations in the nycthemeral
(day vs night) patterns in both behaviour and hepatic gene expression
[24]. Importantly, the maternal environment has the capacity to alter
clock gene expression in the developing liver, causing changes that
persist postpartum [25]. For example, in non-human primate liver,
exposure to a maternal high-fat diet signiﬁcantly alters expression of
fetal hepatic Npas2, a paralog of the clock transcription factor [26]. In
rodents, offspring of obese dams show reduced hepatic expression of
both circadian and metabolic genes, which is associated with altered
mRNA dynamics [11]. More recently it has been shown that maternal
obesity interacts with an obesogenic post-weaning diet to disrupt the
canonical rhythmicity of gene expression in the liver, and alters the
DNA methylation levels at both the Bmal1 and Per2 promoters [27].
Recent ﬁndings suggest that the Clock and Bmal1 heterodimer sense
the metabolic status of the cell via a functional interaction with the
NAD+ dependent deacetylase SIRT1 [28,29]. SIRT1 belongs to a class of
sirtuin proteinswith roles in circadian rhythms, mitochondrial metabo-
lism, and aging [30–32]. Moreover, recent ﬁndings have shown that
SIRT3, a mitochondrial protein deacetylase, is down-regulated in
response to maternal fat exposure and is involved in the development
of fatty liver disease [33,34]. Thus, it is possible that SIRT1 and SIRT3
functionally link mitochondrial metabolism, lipid homeostasis, circadian
biology and age-associated metabolic decline.
In light of these ﬁndings we tested the hypothesis that HF feeding
during development could contribute to the priming of severe fatty
liver disease, through altered circadian biology, clock gene expression,
and altered regulation of CCGs with key roles in lipid homeostasis.
2. Methods
2.1. Animal model
All animal procedures were carried out in accordance with the
United Kingdom Animals (Scientiﬁc Procedures) Act 1986 and were
approved by the local ethics review committee. Female C57/BL6J mice
were maintained under a 12-hour light/dark cycle (lights on at 07.00 h),and at a constant temperature of 22± 2 °Cwith food andwater available
ad libitum. Damswere randomly allocated to one of two diets: control (C;
7% kcal fat; Special Dietary Services, UK), or a high fat diet (HF; 45% kcal
fat; Special Dietary Services, UK). We have previously used this HF diet
to bring about an obese phenotype in both the pregnant dams and their
offspring [10]. Dams were fed the designated diet 6 weeks pre-
pregnancy, through to pregnancy and lactation. Pregnant dams were
allowed to deliver their pups, and litter size was standardized to six
pups (three males and three females, whenever possible) to ensure that
no litterwas nutritionally biased.Offspringwere randomly allocated to ei-
ther the C or HF diet at weaning at 3 weeks of age resulting in 4 offspring
groups; C/C, C/HF, HF/C and HF/HF. These offspring were fed the diets for
the next 12 weeks. At 15 weeks of age, male offspring were killed by cer-
vical dislocation at 2 time points during the 24-hour light-dark period, at
3 pm (Zeitgeber time 8 or ZT8; 8 h into the light or day period) and at
3 am (ZT20; 8 h into the dark or night period). Liver tissue was immedi-
ately frozen in liquid nitrogen and stored at−80 °C or parafﬁn embedded
for histological analysis.
2.2. Day-night changes in food intake and energy expenditure
Food intake and energy expenditure were recorded over a 24-hour
light–dark cycle in the four offspring groups (C/C, C/HF, HF/C and HF/
HF, n = 6–10 per offspring group) using a closed modular indirect
calorimetric system at 12 weeks of age (Oxylet, Panlab SLU, Spain).
Oxygen consumption (VO2) and carbon dioxide production (VCO2)
were recorded at 5-min intervals using a computer-assisted data acqui-
sition program (Metabolism; Panlab SLU, Spain) over a 24-hour period.
From this, the animal’s energy expenditure (EE; in kcal/day/body
weight0.75) was calculated. Food intake was continuously measured
using an extensiometric food weight transducer device (Panlab SLU,
Spain). To determine day and night differences in food intake and
energy expenditure between the offspring groups, the mean values
were calculated during the light and dark phases of the cycle for each
mouse in each treatment groups.
2.3. Glucose tolerance test
Glucose tolerance test was performed after an overnight fast at
14 weeks of age. Fasting glucose concentration was measured in
whole blood obtained from the tail vein before the fasted mice were
intraperitoneally injected with D-glucose (2 g/kg mouse body weight),
and blood glucose concentration was measured using a glucometer
(Aviva Accu-Chek, Roche Diagnostics Ltd., UK) at 15, 30, 60 and 120min.
2.4. Evaluation of steatosis by point counting
Evaluation of steatosis was done by point counting. Previous studies
have shown that the point counting method of evaluating steatosis had
a strong and signiﬁcant correlation to hepatic triglyceride levels [53].
Brieﬂy, captured digital images of liver sections stainedwith hematoxy-
lin and eosin (H&E) were projected on an LCD monitor. For each H&E
stained liver sections, sequential images were taken at 20× magniﬁca-
tion across a section (avoiding large vessels). A total of 3 stained sec-
tions were scanned per animal (n = 4 animals per treatment group).
Using a computer software FIJI (http://ﬁji.sc/Fiji), a 10 × 10 grid system
of 100 test points (PT) was superimposed on the image ﬁeld. The per-
centage volume density of hepatic steatosis (Vv[steatosis, liver]%) was
then estimated as the ratio of the points hitting the vesicles of fat (Pp)
compared to the number of test points: Vv[steatosis, liver]% =
(Pp[steatosis] / PT) × 100.
2.5. Histological analysis
The Kleiner scoring systemwas used to assess the severity of NAFLD
[35]. An activity score (AF) was generated by adding the individual
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33–66%= 2, N66%= 3); ballooning (none= 0, few= 1, prominent=
2); and lobular inﬂammation (none = 0, b2 foci = 1, 2–4 foci = 2, N4
foci = 3). A score of b3 correlates with mild NAFL, a score of 3–4
correlates with moderate NAFL and a score of 5 or more correlates
with NASH. The average score for each histological characteristic in
each group was used as previously [10].
2.6. NAD/NADH assay
NAD+ and NADH were extracted from left lobe liver samples and
quantiﬁed using an enzymatic calorimetric method (Enzychrom,
BioAssay Systems, CA, USA) according to the manufacturer's instructions.
Both absolute levels and NAD+/NADH ratios are presented.
2.7. Plasma lipid assay
Day (ZT8) and night (ZT20) triglyceride levels in plasma samples
(n = 5 per group, per time point) was measured with a commercial
enzymatic colorimetric method (cholesterol 50 kits; Sigma, Poole,
UK), and plasma NEFA was measured by an enzymatic method (Alpha
Laboratories, Eastleigh, UK).
2.8. Relative gene expression
Total RNA was isolated from 0.025 g of left lobe of the liver from
15 week-old offspring (n = 5 per time point and dietary group) using
Trifast reagent (Peqlab, Germany) according to the manufacturer's
instructions. RNA quantiﬁcation, quality, and integrity were determined
via (260/230 and 260/280 ratios and concentrations) a NanoDrop
spectrophotometer (Thermo Fisher Scientiﬁc, UK) and agarose gel
electrophoresis. Total RNA (1 μg) was reverse transcribed to cDNA
using reverse M-MLV transcriptase (Promega, UK). Samples were then
incubated at 37 °C for 1 h, 42 °C for 10 min, followed by an enzyme
activation step at 75 °C for 10min. The cDNA synthesis was then diluted
to a concentration of 5 ng/μL before ampliﬁcation. Expression of the
Sirt1, Sirt3, the core clock genes (Clock, Bmal1, Cry1, Cry2, Per2), and
the lipogenic transcription factors Rev-Erbα, Rev-Erbβ, RORα, and
Srebp1c were determined at ZT8 and ZT20, otherwise referred to as
day and night, by quantitative real time reverse transcriptase polymer-
ase chain reaction (qRT-PCR; Applied Biosystems 7500 Fast Real-time
PCR Thermal Cycler). Expression of OPN was determined at ZT8 only.
We used the housekeeping genes (HKG) YWHAZ and βactin to deter-
mine relative gene expression, since they were the most stably
expressed gene following challenge with HF diets and at different circa-
dian time points [36]. PCR ampliﬁcation was performed for 50 cycles.
Following an initial enzyme activation step for 10 min at 95 °C, each
cycle consisted of denaturation for 15 s at 95 °C, annealing for 30 s at
50 °C and 15 s at 72 °C. Analysis of duplicated samples determined
that the intra-assay coefﬁcients of variability (CV) was N5%.
2.9. Statistical analysis
Data are expressed as mean± SEM, and a signiﬁcant difference was
accepted at p b 0.05. For 24-hour metabolic phenotype measurements,
day (light period) or night (dark period) area under the curve (AUC)
analysis was performed on individual animals. A one way analysis of
variance (ANOVA) was performed between offspring groups with
Bonferroni post-hoc analysis for multiple comparisons, to determine
the groups which signiﬁcantly differed. For blood analysis, mean day
(ZT8) and night (ZT20) valueswere analyzed by ANOVA and Bonferroni
post-hoc tests. For gene expression analysis, mean delta delta CT values
for each offspring group at either day (ZT8) or night (ZT20) were tested
for signiﬁcant difference using ANOVA followed by Bonferroni post-hoc
analysis.3. Results
3.1. Food intake and energy expenditure is perturbed in 15 week old male
offspring exposed to high fat diets during development
To determine the effect of increased fat exposure on circadian phys-
iology, we measured nycthemeral patterns of food intake and energy
expenditure (EE) in adult offspring. Control offspring showed a noctur-
nal phenotype and consumed food mainly during the subjective night
(Fig. 1a). The canonical night-time feeding behavior was also observed
in the HF/C offspring. In contrast, both offspring groups fed a HF diet
during adulthood ate signiﬁcantly more during the day than the control
offspring (Fig. 1a; p b 0.01, C/HF or HF/HF vs C/C). Although total food
intake was greatest in the C/HF offspring, these offspring also had the
signiﬁcantly higher EE in both the day and the night than other offspring
groups (Fig. 1b; p b 0.05, C/HF vs C/C). It is plausible to suggest that such
an increase in EE offsets the increased caloric intake observed in the
C/HF offspring, and limits furtherweight gain. Thismaypartially explain
why the HF/HF offspring, which lack increased EE, are signiﬁcantly
heavier than other offspring groups (Fig. 1c; p b 0.001, C/HF vs C/C;
p b 0.0001, HF/HF vs C/C). Although speculative, the maternal HF
challenge may alter metabolic capacity in the offspring. In the HF/HF
offspring this prevents an adaptive increase in EE that would otherwise
limit further weight increase, while in the HF/C this manifests as signif-
icantly higher body weight in the absence of increased food intake.
3.2. Offspring exposed to HF diets during development are primed to devel-
op severe fatty liver in adulthood
We have previously shown that female offspring exposed to high fat
diets during development are primed to develop severe fatty liver
disease, characterized by micro and macrovesicular steatosis, ballooning
degeneration, and inﬂammation [10]. In the present study, we asked
whether male offspring developed a similar condition. Steatosis was
directly quantiﬁed by point counting to show that while HF/C offspring
had increased fat accumulation compared to control, fat accumulation
was further increased in the C/HF offspring, and further still in their
HF/HF counterparts (Fig. 1d). Histological analysis and Kleiner scoring
methods were used to compare the severity of liver disease between
offspring groups. Histological analysis conﬁrmed that while offspring
exposed to a HF diet during adulthood (C/HF) displayed marked hepatic
lipid accumulation, offspring exposed to HF diets during development
and later life (HF/HF) displayed a severe liver histopathology akin to
human NASH (Fig. 1e). In conﬁrmation, histological scoring of liver
sections revealed that livers from the HF/HF offspring had scores of 5 or
greater, which were consistent with the features of NASH (Fig. 1f).
Glucose tolerance tests (GTT) were performed to determine the
effect of HF feeding on glucose homeostasis. GTT revealed that baseline
fasting glucose levels were signiﬁcantly higher in the HF/HF offspring
compared to the other offspring groups vs C/C (Fig. 1g p b 0.01). Follow-
ing (intraperitoneal) IP injection of glucose, circulating glucose levels
remained signiﬁcantly elevated, even at after 2 h post-IP in both groups
of offspring exposed to a HF diet during development (p b 0.05 in HF/C
and p b 0.01 in HF/HF vs C/C) and those fed a HF diet in later life
(p b 0.05, C/HF vs C/C). Since this elevated blood glucose and reduced
glucose clearance is associated with insulin resistance we measured day
and night circulating insulin levels. (Fig. 1h). Insulin was signiﬁcantly
higher in the C/HF offspring during the night (p b 0.001, C/HF vs C/C).
However, HF/HF offspring were hyperinsulinemic during both the
day and night, and the nycthemeral pattern of insulin production
was seemingly abolished (p b 0.001, HF/HF vs C/C).
Since murine models readily develop NAFLD, but not NASH, we set
out to measure OPN expression, a marker of ﬁbrosis and severe fatty
liver disease in offspring liver (Fig. 2a). We found that OPN expression
signiﬁcantly increased the livers of HF/HF offspring (p b 0.001 in HF/
HF vs C/HF), but not in any other offspring groups. This suggests that
Fig. 1. 15weekoldmale offspring exposed to high fat diets during development and adulthoodhaveperturbed nycthemeral (day vs night) rhythms of food intake and energy expenditure,
and also develop severe fatty liver and imbalanced hepatic cellular redox status. (a.) Total amount of food intake ofmale offspring from each dietary group, during the 12 h light (daytime,
open bars) and 12h dark (nighttime, closed bars) periods. (b.) Energy expenditure levels inmale offspring from each dietary group, during the 12h light (open bars) and 12 h dark periods
(closed bars). (c.) Bodyweight (recorded at ZT8) of the offspring at 15weeks of age. (d.) Percentage of steatosis in liver sections determined by point counting (e.) Hematoxylin and eosin
stained liver sections from 15 week old male offspring. C/C and HF/C offspring show normal liver architecture. C/HF offspring livers exhibit lipid accumulation. HF/HF livers contain
signiﬁcant lipid accumulation and ballooning degeneration. (f.) Kleiner scores for offspring liver (n = 4 for each offspring group), show that C/C and HF/C are histologically normal, C/
HF show a histological phenotype similar to human non-alcoholic fatty liver (NAFL), and HF/HF offspring liver have the appearance of non-alcoholic steatohepatitis (NASH). (g.)
Fasting blood glucose over 2 h following bolus intraperitoneal (IP) injection of glucose (inverted arrow). Inset histogram depicts the area under the curve (AUC) levels over the 2-hour
monitoring period. (h.) Circulating insulin levels during the 12 h light (daytime, open bars) and 12-hour dark (nighttime, closed bars) periods. For each analysis offspring groups were
compared against C/C, where *p b 0.05, **p b 0.01, ***p b 0.001 or ****p b 0.0001 vs C/C.
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predisposes to the development of amore severe fatty liver disease akin
to human NASH.
3.3. Offspring exposed to a HF diet during development and adulthood have
imbalanced cellular redox status and altered metabolic state
To determine whether HF feeding during development resulted in
alterations in cellular redox status, we measured the availability of
NAD+ and NADH in offspring liver. Offspring exposed to a HF diet
during both development and adulthood (HF/HF) had signiﬁcantly
reduced hepatic NAD+ (Fig. 2b; p b 0.01, HF/HF vs C/C). In contrast,
hepatic NADH concentrations were similar in all offspring groups
(Fig. 2c). Consequently, the NAD+/NADH ratio was signiﬁcantly lower
the in HF/HF offspring compared to all other offspring groups (Fig. 2d;
p b 0.05, HF/HF vs C/C).
3.4. Offspring exposed to HF diets have altered lipid homeostasis
To determine the effect of HF feeding on circadian lipid homeostasis,
wemeasured circulatingnon-esteriﬁed fatty acids (NEFA) and triglycer-
ides (TG) in each offspring group at a speciﬁc time during the day (ZT8),
or night (ZT20). Offspring exposed to a HF diet at any life stage, had
increased daytime circulating NEFA compared to C/C offspring (Fig. 2e;
p b 0.001, C/HFvs C/C; p b 0.01, HF/C orHF/HF vs C/C). Similarly, daytime
TG levels were signiﬁcantly higher in all offspring fed a HF diet (Fig. 2f;
p b 0.01, C/HF vs C/C; p b 0.05, HF/C or HF/HF vs C/C). Moreover,offspring fed a HF diet in the post-natal period showed an increase in
nighttime TGs compared to control offspring (p b 0.05, C/HF or HF/HF
vs C/C).3.5. Hepatic sirtuin and core clock protein expression is perturbed in
offspring exposed to a HF diet during early life and adulthood
Wehad previously shown thatmitochondrial function is impaired in
offspring exposed to a HF diet during development [10]. Hence we
determined the gene expression of mitochondrial Sirt3 following HF
feeding. Sirt3 was signiﬁcantly reduced in livers of offspring that had
been fed a HF diet during adulthood (Fig. 3a; p b 0.01, C/HF vs C/C),
corresponding to a−3.8 fold decrease (Table 1). Nighttime expression
of Sirt3was further reduced (−12.5 fold, Table 1) in offspring that had
been exposed to a HF diet during both development and adulthood
(p b 0.01, HF/HF vs C/C). However, expression of Sirt3was not reduced
in the livers of offspring that had been exposed to a HF diet during
development only (i.e. the HF/C group). In contrast, Sirt1 expression
was reduced by−1.9 (Table 1) during the day in the livers of offspring
exposed to a HF diet during the developmental period (Fig. 3b; p b 0.05,
HF/C vs C/C.), a decline that was exacerbated by post-natal HF feeding,
showing 5.7 and 8 fold reduction (Table 1) in the C/HF and HF/HF
offspring, respectively (Fig. 3b; p b 0.001, C/HF or HF/HF vs C/C.). In
addition, to validate the reduction in Sirt1 and Sirt3 gene expression,
we measured protein levels of SIRT1 and SIRT1 (Supplemental Fig. 1a
and b, respectively) to show that HF diets reduce signiﬁcantly reduce
Fig. 2.As ameasure of ﬁbrosis (a.) OPN gene expressionwasmeasured in offspring liver. Concentration of pyridine nucleotides (b.) NAD+, (c.) NADH in offspring liver (left lobe), and (d.)
the NAD+/NADH ratio in offspring liver. Circulating levels of (e.) non-esteriﬁed fatty acids (NEFAs) and (f.) triglycerides were determined from mouse plasma taken during the light
(daytime at ZT8, open bars) or dark (nighttime at ZT20, closed bars) periods (for each analysis offspring groups were compared against C/C, where *p b 0.05, **p b 0.01 or ***p b 0.001
vs C/C.
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offspring (p b 0.001 HF/HF vs C/C).
Since SIRT1 interacts with CLOCK in an NAD+ dependent manner
[18,28], we measured the expression of core clock genes and CCGs
with key roles in lipid homeostasis. Here, we show that Clock transcript
levels were robustly expressed in livers of all offspring (Fig. 3c). In
contrast, hepatic daytime gene expression of Bmal1 (Fig. 3d) showed a
22 fold increase (Table 1) in offspring that have been fed a HF diet during
development and adulthood, compared to control offspring (p b 0.01;
HF/HF vs C/C). In addition, Bmal1 expression, which showed a 13.75, 6
and 8.35 fold increase in the day in the C/C, C/HF and HF/HF offspring
respectively, was reversed in the HF/HF offspring (Table 2;−2.2 fold
decrease in HF/HF).
CRY2 forms a functional heterodimer with PER2which has an inhib-
itory effect on CLOCK/BMAL1. Interestingly, while the hepatic expres-
sion of Per2 remains unperturbed following HF feeding (Fig. 3e),
daytime expression of Cry2 was signiﬁcantly altered in offspring
exposed to a HF diet (Fig. 3f; p b 0.05, HF/C or HF/HF vs C/C). The
nycthemeral pattern was also altered in the HF/C and HF/HF offspring,
and showed higher expression in the night (Table 2; 5.18 and 2.4 fold
respectively), compared to higher expression in the day on both the
C/C and HF/HF offspring.
We next determined the expression of CCGs with important roles in
lipid metabolism. Speciﬁcally, the nighttime expression of both Rev-
Erbα and Rev-Erbβ was signiﬁcantly increased in the HF/HF offspringcompared to control (Fig. 3g and h, respectively; p b 0.05, HF/HF vs
C/C). In addition, the daytime expression of Rev-Erbα was also signiﬁ-
cantly increased compared to control (Fig. 3g; p b 0.05, HF/HF vs C/C).
The expression Rev-Erbβ is normally much higher in the day than in
the night (Table 2;−6.73 in C/C). However, with increasing exposure
to a HF diet, the nycthemeral pattern of Rev-Erbβ expression is lost
(Table 2;−3.22,−1.59,−1.23 fold in C/HF, HF/C and HF/HF, respec-
tively). The orphan nuclear receptor RORα, also a key modulator of
lipid metabolism, was similarly perturbed in the HF/C offspring in the
day (Fig. 3i; p b 0.05, HF/C vs C/C) and night (Fig. 3i; p b 0.001, HF/C
vs C/C). Both Rev-Erb and RORαmay regulate lipid metabolism through
the lipogenic transcription factor Srebp1c. Expression of this gene was
increased in livers from both the C/HF and HF/HF offspring (Fig. 3j;
p b 0.05, C/HF and HF/HF vs C/C), consistent with increased hepatic fat
accumulation in these groups.
4. Discussion
Our ﬁndings suggest that the developmental priming of severe fatty
liver involves a complex molecular pathology, involving alterations in
circadian biology and lipogenesis. Speciﬁcally, we show that increased
fat intake during development is associated with disruptions in circadian
physiology, cellular redox status, sirtuin abundance, and transcription of
core clock genes and down-stream lipogenic transcription factors (a sche-
matic representation of this is illustrated in Fig. 4). These molecular
Fig. 3.Mean relative hepaticmRNA expression of the sirtuins (a.) Sirt1 and (b.) Sirt3; of genes involved in co-ordinating circadian rhythms (c.) Clock, (d.) Bmal1, (e.) Per2, and (f.) Cry2; and
downstream lipogenic transcription factors (g.) Rev-Erbα, (h.) Rev-Erbβ, (i.) RORα, and (j.) Srebp1c during the light (daytime at ZT8, open bars) or dark (nighttime at ZT20, closed bars)
periods. For each analysis offspring groups were compared against C/C, where *p b 0.05, **p b 0.01 or ***p b 0.001 vs C/C.
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effects on hepatic lipid homeostasis, increasing the likelihood of develop-
ing severe fatty liver disease in adulthood.
Since a growing number of young individuals are exposed to diets
that are rich in fat during critical periods of development, it is likely
that excess fat intake in early life contributes to the “primed” onset of
NAFLD in young adults [37]. In this study we aimed to further under-
stand the mechanisms underlying developmentally primed severe
fatty liver disease. Here, we show that feeding a HF diet leads to
NAFLD, however, the livers of male offspring of HF-fed mothers whoare also given a HF diet in post-natal life (HF/HF offspring) show
features pertaining to a more severe NASH-like phenotype. These
results recapitulate our previous ﬁndings in female offspring [10], and
moreover, demonstrate that the developmental priming of severe
fatty liver is not sex-speciﬁc.
To further understand the pathogenesis of developmentally primed
metabolic disorder, it is useful to examine differences in circadian
physiology between offspring groups. Both groups of offspring fed a HF
diet in the post-natal period (HF/HF and C/HF) show changes in metabo-
lism akin to pre-clinical metabolic disorder, such as hyperglycemia,
Table 1
Nighttime and daytime fold changes versus corresponding C/C levels.
Daytime values vs C/C daytime values Nighttime values vs C/C nighttime values
C/HF HF/C HF/HF C/HF HF/C HF/HF
Sirt3 −3.81 ± 0.66⁎⁎ −1.22 ± 0.32 −2.19 ± 0.58 −2.31 ± 0.38 1.41 ± 0.52 −12.51 ± 2.06
Sirt1 −5.71 ± 0.66⁎⁎⁎ −1.97 ± 0.25⁎⁎ −8.08 ± 1.30⁎⁎⁎ 1.19 ± 0.27 1.23 ± 0.51 −6.22 ± 2.03
Clock −1.16 ± 0.42 −1.11 ± 0.21 −1.05 ± 0.20 1.14 ± 0.22 −1.59 ± 0.76 1.36 ± 0.12
Bmal1 3.30 ± 1.67 −1.89 ± 0.75 22.20 ± 10.08⁎ 1.45 ± 0.32 −3.12 ± 0.86 −1.25 ± 0.34
Per2 1.12 ± 0.15 −1.28 ± 0.25 1.23 ± 0.32 1.82 ± 0.41 2.16 ± 0.48 2.25 ± 0.56
Cry2 1.29 ± 0.39 −2.38 ± 0.32 −3.65 ± 1.82 −2.16 ± 0.61 3.65 ± 1.82 1.10 ± 0.24
Rev-Erbα 1.62 ± 0.37 1.46 ± 0.19 1.51 ± 0.19 1.74 ± 0.28 1.74 ± 0.60 3.37 ± 1.03
Rev-Erbβ −1.27 ± 0.14 −1.73 ± 0.19 −1.93 ± 0.21 1.65 ± 0.24 2.44 ± 0.68⁎ 2.83 ± 0.38⁎⁎
RORα −1.71 ± 0.19⁎ −1.75 ± 0.20⁎ 1.02 ± 0.14 −1.54 ± 0.55 1.92 ± 0.87 1.25 ± 0.21
Srebp1c 1.14 ± 0.28 1.73 ± 0.39 1.97 ± 0.31⁎ 3.32 ± 0.69⁎⁎ 1.83 ± 0.92 3.16 ± 0.49⁎
⁎ p b 0.05.
⁎⁎ p b 0.01.
⁎⁎⁎ p b 0.001 vs corresponding daytime or nighttime C/C levels.
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there are a number of interesting phenotypic differences between these
two offspring groups. Firstly, the C/HF mice display increased insulin
levels at night, when food intake and insulin levels are expected to con-
comitantly rise, albeit elevated due to themacronutrient composition of
the HF diet. In contrast, the HF/HF mice show hyperinsulinemia in both
the day and the night, highlighting marked changes in circadian physi-
ology following developmental HF exposure, and suggesting that these
offspring are insulin resistant, a known factor in the pathogenesis of
fatty liver disease. In addition, the C/HF offspring also show increased
energy expenditure and remain glucose tolerant. It is plausible that
this is an adaptive response to increased energy intake and fat con-
sumption in a heavier, yet healthy organism. These adaptations, namely
increased EE may offer protection against increased ectopic lipid accu-
mulation and severe fatty liver disease. In contrast the HF/HF offspring
fail to increase energy expenditure in response to increased energy
intake, and also exhibited pronounced hyperglycemia, at both baseline
and post-glucose bolus, which may be indicative of a developmentally
programmed inability to respond to nutritional excess. Thus the HF/
HF are less able to response to increased fat consumption, and unlike
their C/HF counterparts, who were fed the same diet but did not
experience a developmental HF challenge, are not protected against
increased ectopic lipid accumulation and continue to develop severe
fatty liver disease.
Reducedmetabolic capacity in theHF/HF offspring is consistentwith
our previous work, which showed that developmental fat exposure can
impair mitochondrial electron transport chain (ETC) function and
metabolic capacity in offspring livers [10]. In further support, in the
present study we observe impaired redox status and signiﬁcantly
reduced Sirt1 and Sirt3 gene expression in the HF/HF offspring. Impor-
tantly, SIRT3 is thought to interact with subunits of complexes I and II
of the electron transport chain (ETC) directly, leading to increasedTable 2
Nighttime fold changes versus daytime levels.
C/C C/HF
Sirt3 −1.52 ± 0.40 1.08 ± 0.3
Sirt1 −2.77 ± 0.35⁎⁎ 2.44 ± 0.5
Clock 1.95 ± 0.53 1.93 ± 0.3
Bmal1 13.75 ± 3.78⁎⁎⁎ 6.06 ± 1.3
Per2 −1.78 ± 0.18 −1.13 ± 0.1
Cry2 −1.68 ± 0.22 −4.66 ± 1.3
Rev-Erbα −11.54 ± 2.29⁎⁎⁎ −10.80 ± 2.4
Rev-Erbβ −6.73 ± 0.73⁎⁎⁎⁎ −3.22 ± 0.8
RORα −1.20 ± 0.14 −1.08 ± 0.1
Srebp1c −2.48 ± 0.56 1.17 ± 0.2
⁎ p b 0.05.
⁎⁎ p b 0.01.
⁎⁎⁎ p b 0.001.
⁎⁎⁎⁎ p b 0.0001 vs corresponding daytime or nighttime C/C levels.mitochondrial efﬁciency [38]. Thus, it is plausible to suggest that
prolonged exposure to diets containing excessive amounts of fat could
alter nutrient sensing via mitochondrial sirtuins and directly inﬂuence
mitochondrial capacity and disease susceptibility.
Our ﬁndings are consistent with recent studies implicating SIRT3 as
a key player in fatty liver disease pathogenesis [39]. Interestingly, SIRT3
mediated lipotoxicity is thought to involve hyperacetylation of mito-
chondrial proteins and dysregulation of the electron transport chain
(ETC) enzymes, leading to protein oxidation and impairedmitochondri-
al function [40]. Since ETC enzyme function is impaired in offspring
exposed to a HF diet during development, we suggest that SIRT3 reduc-
tion plays an important role in developmentally primed fatty liver. How
SIRT3 becomes reduced is unclear, however, SIRT3 reduction is often
coupled to reduced NAD+ levels [39], and supplementation with the
NAD+ precursor nicotinamide ribose activates SIRT3 and enhances
oxidative metabolism to protect against HF-induced metabolic abnor-
malities [41]. Here, we show that NAD+ is markedly reduced in the
livers of offspring from obese mothers that were also fed a HF diet in
later life, suggesting that depleted NAD+ levels in these HF/HF offspring
contributes to reduced SIRT3 abundance. Whether increased fat intake
activates NAD+ consuming enzymes to deplete the cellular pool of
NAD+, altering redox balance and reducing sirtuin abundance remains
to be tested. Nonetheless, in support of this premise Sirt1 gene expression,
for which NAD+ is also a rate-limiting co-substrate, is also down-
regulated in the livers of HF/HF offspring.
Multiple cellular processes play in important role in maintaining the
NAD+/NADH ratio. For example, during glycolysis, beta-oxidation, and
the citric acid cycleNAD+ is reduced toNADH.Once in themitochondria
NADH is oxidized by the electron transport chain enzymes during
oxidative phosphorylation. Since we have previously shown that the
HF/HF offspring exhibit impaired oxidative metabolism through
reduced electron transport chain activity (Bruce et al. [10]), it is possibleHF/C HF/HF
5 1.13 ± 0.42 −8.68 ± 2.51⁎⁎
8⁎ −1.14 ± 0.29 −2.13 ± 0.52
4 1.38 ± 0.32 2.15 ± 0.19⁎⁎
4⁎⁎⁎ 8.35 ± 2.89⁎⁎ −2.02 ± 0.92
8 1.56 ± 0.42 1.03 ± 0.25
0⁎ 5.18 ± 1.91⁎⁎ 2.40 ± 0.53⁎
6⁎⁎⁎ −9.82 ± 1.26⁎⁎⁎ −5.18 ± 0.64⁎⁎
4⁎ −1.59 ± 0.44 −1.23 ± 0.15
7 2.79 ± 0.80⁎⁎ 1.01 ± 0.17
4 1.28 ± 0.64 −1.55 ± 0.24
Fig. 4. Hypothetical schematic representation of how maternal high fat and post-natal high fat (HF) diet alters sirtuin and clock gene expression leading to severe hepatic steatosis in
offspring liver. A HF diet during both early and post-natal life reduces sirtuin levels and alters cellular energy status (reduction in NAD+ levels and NAD/NADH ratio). This is associated
with desynchronization of circadian clock gene activity and upregulation of downstream lipogenic transcription factors such as Srebp1c to developmentally prime the lipogenic
pathway, resulting in further up-regulation of fat accumulation.
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although their livers are able to readily reduce NADH during catabolic
redox reactions (in response to increased fat intake), their ability to
replenish NAD+ reserves is lacking due to impaired oxidative capacity.
Conversely, theC/HF offspring,whichdo not have an impaired oxidative
metabolism, are able to maintain redox balance even during increased
food intake. Similarly, the HF/C offspring, whichmay also have develop-
mentally impaired electron transport chain enzymes, are not burdened
with the post-natal challenge of a high fat diet, and thus are also able to
maintain a favorable NAD+/NADH ratio.
As the liver ages it is more prone to metabolic changes such as
ectopic lipid accumulation [42]. This is consistent with growing
evidence suggesting that fatty liver disease is more prevalent in older
individuals [43,44]. Here, we show that HF feeding during early and
later life is associated with depleted NAD+ reserves and reduced sirtuin
abundance, both established hallmarks of metabolic aging [31]. Impor-
tantly, offspring exhibiting these hallmarks also display serve fatty
liver disease at a fairly young age (15 weeks old). Therefore, we suggest
that HF exposure during development may impose chronic metabolic
stress, culminating in accelerated organ decline and a propensity to
develop fatty liver disease at relatively early stages of life. Our ﬁndings
begin to shed light on themechanisms underlying HF-induced develop-
mental programming of fatty liver disease and premature organ decline.
Here, we show that clock gene expression is deregulated in offspring
fed a HF diet. Since SIRT1 functionally interacts with the core clock
genes, it is plausible to suggest that our observed changes in NAD+
and sirtuin abundance play a role in deregulated clock gene expression.
We show that hepatic Bmal1 and Cry2 gene expression are profoundly
altered in offspring of HF fed mothers. It is important to highlight that
the simultaneous reduction of Cry2 and increase in Bmal1 observed in
the HF/HF offspring are directional changes that are consistent with
the current model of the core-clock transcriptional feedback loops.
Our ﬁndings suggest that Bmal1 expression is inﬂuenced by nutritional
challenges, and that offspring of dams fed a high fat diet, that are fed a
HF diet in post-natal life have signiﬁcantly up-regulated Bmal1 expres-
sion in liver. Importantly, recent studies suggest that Bmal1 is a novel
metabolic regulator that is able to couple circadian rhythm and lipid
metabolism. Bmal1 knockoutmice showboth impaired insulin signalingand lipid homeostasis [45]. Recent studies have shown that mice with
either a global or hepatic Bmal1 deﬁciency have reduced lipogenic
gene expression following re-feeding [46]. Conversely, Bmal1 over
expression in the liver is sufﬁcient to elevate the expression of genes
involved in de novo lipogenesis, such as Srebp1c and Fasn (Zhang et al.
[29]). Again, this is consistent with our observations showing the
concurrent increase in CCGs (Rev-Erb, RORα and Srebp1c) with key
roles in lipid lipogenesis. Speciﬁcally, Rev-Erbα is known to regulate
the Srebp1c promoter and mRNA expression [47]. Here we show that
in the C/HF and HF/HF offspring we see a subtly different pattern of
hepatic “circadian” Srebp1c gene expression, but overall the expression
of Srepb1c was elevated compared to the control offspring, as expected
in steatotic livers. Nonetheless, Srebp1c levels were the highest the HF/
HF group. Interestingly, while there was a trend towards increased
Rev-Erbα expression in the C/HF group, only the HF/HF group show
signiﬁcantly elevated expression. Thus, we hypothesize that the elevated
Rev-Erbαmay be associated with increased Srepb1c expression observed
in the HF/HF offspring. However, we cannot rule out other possible path-
ways that may be contributing to the increased expression of both of
these genes, following differential dietary exposures between the
offspring groups. Taken together our results suggest that a deregulated
core clock gene-lipogenic transcription factor axis culminates in elevated
hepatic fat accumulation and disease progression (Fig. 4).
The impact of HF diets on clock gene expression and lipid homeosta-
sis in the liver has been the subject of intense research of late. Nonethe-
less, controversy remains as to whether HF diets can signiﬁcantly affect
hepatic clock gene expression. Relatively short term HF feeding in mice
produced a metabolic syndrome phenotype, but did not alter hepatic
clock gene expression [48]. In contrast, recent studies have shown that
HF feeding leads to changes in circadian locomotor activity, food intake,
and hepatic clock gene expression [49,50]. In addition, long term HF
feeding can have a major impact on clock gene expression in the liver
[51]. It is therefore possible that the length or timing of HF exposure
may have variable effects on the liver. Importantly, a recent study
showed that developmental HF exposure disrupts circadian rhythmicity
and contributes to metabolic syndrome including hepatic steatosis in a
rat model of maternal obesity [11]. Maternal obesity has also been
shown to program offspring NALFD through disruption of circadian
592 K.D. Bruce et al. / Biochimica et Biophysica Acta 1861 (2016) 584–593rhythms and clock gene expression in offspring livers in mice [27]. Our
data are both consistent with, and extend these recent observations,
which show that hyper-caloriﬁc diets in utero can permanently disrupt
the chronobiological network [27]. Collectively these ﬁndings highlight
the importance of the developmental period for liver development, and
that nutritional exposures during this time can persistently alter clock
genes to permanently alter liver metabolism and increase disease
susceptibility in later life.
In conclusion, during the last decade fatty liver disease has become
themost common chronic liver disease in young individuals [52]. Ther-
apies tend to focus on treating the co-presenting metabolic imbalances
such as obesity and increased BMI, and often have limited efﬁcacy
treating liver disease itself. Pharmacological interventions that target
the underlying mechanism have considerable potential to prevent the
onset of severe liver disease and additional features of the metabolic
syndrome. Our ﬁndings highlight the importance of nutrition during
early life as a promising area for intervention. Although further research
in this area is warranted to fully understand the multifaceted nature of
developmentally primed liver disease, our mechanistic insights suggest
that supplementationwith factors able to reverse the effects of depleted
NAD+ reserves, and/or SIRT1 and SIRT3 abundance may also have the
potential to alleviate the effects of developmental HF exposure, and
rescue the increased susceptibility to develop severe fatty liver disease
in later life. Ourmodel provides a platform to further our understanding
of the molecular pathogenesis of developmentally primed fatty liver
disease, and to identify novel interventions.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbalip.2016.03.026.
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